XML 38 R22.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Quarterly Financial Information (Unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2017
Quarterly Financial Information (Unaudited) |
Quarterly Financial Information (Unaudited) | 15Quarterly Financial Information (Unaudited)
|  | First |  | Second |  | Third |  | Fourth |  |  |
In millions, except per share amounts |  | Quarter |  | Quarter |  | Quarter |  | Quarter |  | Year
2017: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net revenues |  | $ | 44,514 |  | $ | 45,685 |  | $ | 46,181 |  | $ | 48,385 |  | $ | 184,765
Gross profit |  |  | 6,580 |  |  | 6,935 |  |  | 7,126 |  |  | 7,904 |  |  | 28,545
Operating profit |  |  | 1,793 |  |  | 2,117 |  |  | 2,499 |  |  | 3,108 |  |  | 9,517
Income from continuing operations |  |  | 962 |  |  | 1,097 |  |  | 1,285 |  |  | 3,287 |  |  | 6,631
Income (loss) from discontinued operations, net of tax |  |  | (9) |  |  | 1 |  |  | — |  |  | — |  |  | (8)
Net income attributable to CVS Health |  |  | 952 |  |  | 1,098 |  |  | 1,285 |  |  | 3,287 |  |  | 6,622
Basic earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to CVS Health |  | $ | 0.93 |  | $ | 1.07 |  | $ | 1.26 |  | $ | 3.23 |  | $ | 6.48
Income (loss) from discontinued operations attributable to CVS Health |  | $ | (0.01) |  | $ | — |  | $ | — |  | $ | — |  | $ | (0.01)
Net income attributable to CVS Health |  | $ | 0.92 |  | $ | 1.07 |  | $ | 1.26 |  | $ | 3.23 |  | $ | 6.47
Diluted earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to CVS Health |  | $ | 0.92 |  | $ | 1.07 |  | $ | 1.26 |  | $ | 3.22 |  | $ | 6.45
Income (loss) from discontinued operations attributable to CVS Health |  | $ | (0.01) |  | $ | — |  | $ | — |  | $ | — |  | $ | (0.01)
Net income attributable to CVS Health |  | $ | 0.92 |  | $ | 1.07 |  | $ | 1.26 |  | $ | 3.22 |  | $ | 6.44
Dividends per share |  | $ | 0.50 |  | $ | 0.50 |  | $ | 0.50 |  | $ | 0.50 |  | $ | 2.00
Stock price: (New York Stock Exchange) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
High |  | $ | 83.92 |  | $ | 82.79 |  | $ | 83.31 |  | $ | 80.91 |  | $ | 83.92
Low |  | $ | 74.80 |  | $ | 75.95 |  | $ | 75.35 |  | $ | 66.80 |  | $ | 66.80
|  | First |  | Second |  | Third |  | Fourth |  |  |
In millions, except per share amounts |  | Quarter |  | Quarter |  | Quarter |  | Quarter |  | Year
2016: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net revenues |  | $ | 43,215 |  | $ | 43,725 |  | $ | 44,615 |  | $ | 45,971 |  | $ | 177,526
Gross profit |  |  | 6,744 |  |  | 7,015 |  |  | 7,492 |  |  | 7,606 |  |  | 28,857
Operating profit |  |  | 2,185 |  |  | 2,357 |  |  | 2,824 |  |  | 3,000 |  |  | 10,366
Income from continuing operations |  |  | 1,147 |  |  | 924 |  |  | 1,542 |  |  | 1,707 |  |  | 5,320
Loss from discontinued operations, net of tax |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | (1)
Net income attributable to CVS Health |  |  | 1,146 |  |  | 924 |  |  | 1,540 |  |  | 1,707 |  |  | 5,317
Basic earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to CVS Health |  | $ | 1.04 |  | $ | 0.86 |  | $ | 1.44 |  | $ | 1.60 |  | $ | 4.93
Income (loss) from discontinued operations attributable to CVS Health |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | —
Net income attributable to CVS Health |  | $ | 1.04 |  | $ | 0.86 |  | $ | 1.44 |  | $ | 1.60 |  | $ | 4.93
Diluted earnings per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to CVS Health |  | $ | 1.04 |  | $ | 0.86 |  | $ | 1.43 |  | $ | 1.59 |  | $ | 4.91
Income (loss) from discontinued operations attributable to CVS Health |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | —
Net income attributable to CVS Health |  | $ | 1.04 |  | $ | 0.86 |  | $ | 1.43 |  | $ | 1.59 |  | $ | 4.90
Dividends per share |  | $ | 0.425 |  | $ | 0.425 |  | $ | 0.425 |  | $ | 0.425 |  | $ | 1.70
Stock price: (New York Stock Exchange) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
High |  | $ | 104.05 |  | $ | 106.10 |  | $ | 98.06 |  | $ | 88.80 |  | $ | 106.10
Low |  | $ | 89.65 |  | $ | 93.21 |  | $ | 88.99 |  | $ | 73.53 |  | $ | 73.53

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=68076893&loc=d3e1570-108306 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration